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Systemic sclerosis is a female predominant, a fibrotic autoimmune disease in which 
disturbance in tissue homeostasis and cell turnover including cell apoptosis are central events 
in pathogenesis. Sex hormones are known as the important players in sexual dimorphism of 
autoimmune diseases and in tissue homeostasis. Progesterone influences autoimmune disease 
via its immunomodulatory effect or by its direct action on parenchymal cell function. On the 
other hand, this hormone impacts tissue homeostasis by acting on cell apoptosis in a 
different situation. The objective of this study was to examine the effect of progesterone on 
cellular apoptosis of skin and lung tissues in a mouse model of scleroderma. 
Four group of mice were involved in this study with 10 mice in each. The fibrotic model was 
induced by daily subcutaneous injection of bleomycin for 28 days. One week after initiation of 
fibrosis induction, mice received subcutaneous progesterone alone or with bleomycin for 21 days. 
Control group received only Phosphate buffered saline PBS. After 28 days, under lethal 
anesthesia skin and lung tissues were harvested for histological assessment and hydroxyproline 
measurement. Apoptosis in tissue sections was detected by TUNEL assay technique.  
Bleomycin administration induced fibrosis in skin and lung tissues. Severe apoptosis was 
seen in skin and lung tissues of the bleomycin-treated group (p<0.001 in the skin and p<0.05 
in the lung). Progesterone injection either in the skin (p>0.05) or in the lung (p>0.05) did not 
alter apoptosis in bleomycin-treated animals.  
Our data confirm the role of apoptosis in the pathogenesis of fibrosis in this model; 
however, progesterone does not affect cellular apoptosis in skin and lung tissues of 
bleomycin-injured animals. 
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INTRODUCTION 
 
Systemic sclerosis (SSc) is a chronic connective 
tissue disorder with immunological abnormalities, 
microvascular injury and progressive fibrosis of the 
skin and internal organs.
1
 Progressive fibrosis 
compromises organ functions through the continuous 
accumulation of extracellular matrix (ECM) 
components, especially collagen, and the replacement 
of normal tissue architecture with permanent scar 
tissue.
1,2
 The exact etiology of the disease is unknown. 
B cell, T cell dysregulation and production of 
autoantibodies especially anti-endothelial cell 
antibodies (AECA) and anti-nuclear antibodies are 
important events in the pathogenesis of systemic 
sclerosis (SSc). Anti-endothelial cell antibodies cause 
endothelial cell apoptosis via Fas-mediated cell 
cytotoxicity. Endothelial and epithelial cell apoptosis 
initiate fibrosis by activation of innate and adaptive 
immune responses.
3
 Activation of immune system 
results in activation  of alternatively-activated of M2-
type macrophages , Th2 cells, production of soluble 
mediators and trans-differentiation of fibroblasts to 
myofibroblasts.
4
 Then TGF-, in the downstream of 
Th2 polarization and IL-13 production, enhances 
apoptosis in alveolar epithelial cells and promotes the 
function of myofibroblasts, therefore aggravates the 
vicious cycle of cell death, inflammation and fibrosis.
5
 
Scleroderma is a female-predominant disease.
6
 This 
emphasizes the effect of female hormones on the risk 
and development of the disease.
7
 Female hormones 
influence autoimmune disease by their 
immunomodulatory effects and contribute to immune 
dimorphism.
8
 On the other hand, these hormones 
impact tissue homeostasis by acting on cellular 




Most of our knowledge concerning the action of 
hormones in disease stem from studies scrutinized 
estrogens, and a few data exist about the action of 
progesterone (P) as a major hormone of luteal phase 
and pregnancy. Progesterone by induction of Th2 
immune responses and polarization of M2–type 
macrophages affects the autoimmune disorders.
13,14
 On 
the other hand Progesterone causes cell proliferation 
and is an anti-apoptotic agent in most organs.
9,10,12
 
Excessive apoptosis in ischemia-associated injuries of 
the cardiomyocytes and neuronal cells was inhibited by 
injection of progesterone in animal models.
15,16
 
Collectively, based on the role of autoimmunity, 
ischemia, and apoptosis in the pathogenesis of systemic 
sclerosis and effect of progesterone on the immune 
system and ischemia-induced apoptosis, we thought to 
investigate the role of progesterone on cellular 
apoptosis in a murine model of systemic sclerosis.  
Subcutaneous injection of bleomycin for 4 weeks 
described by Yamamoto et al, induces a mouse model 
of scleroderma.
17
 In this model, skin fibrosis is 
accompanied by lung fibrosis, inflammation, and 
production of autoantibodies. Th2 cytokine profile is 
predominant in sera of mice and TGF- as a central 
mediator in fibrosis increased in affected tissues. These 
finding all are very similar to human systemic sclerosis 





MATERIALS AND METHODS 
 
Animal Model of Systemic Sclerosis and 
Progesterone Treatment 
Six to eight weeks old female BALB/c mice were 
purchased from Pasteur Institute (Tehran, Iran) and 
kept at “Center of Experimental and Comparative 
Studies‟‟. Mice were allowed to acclimate to the 
laboratory conditions for at least 2 weeks prior to the 
beginning of the experiments. Mice were housed in the 
standard laboratory cages at room temperature and 
ambient humidity under a 12-hour reverse light-dark 
cycle with water and rodent laboratory chow, ad 
libitum. All animal experiments were approved by the 
Animal Care Committee of Iran University of Medical 
Sciences (N.: IR. IUMS.FMD.REC1394.25723). Mice 
were randomly divided into the 4 following groups 
with 10 mice in each group: 1) Control ((Phosphate 
buffered saline group, PBS) PBS), 2) Bleomycin 
(BLM), 3) Bleomycin+Progesterone (BLM+P), 4) 
Progesterone for 21 days (P).  
Induction of SSc in mice was performed according 
to Yammamoto et al.
17
 Bleomycin (BLM) (Nippon 
Kayaku, Tokyo, Japan) was dissolved in PBS at a 
concentration of 1.5 U/mL and 100 μL was injected 
subcutaneously daily for 4 weeks into the shaved back 
skin of mice. In order to study the effect of 
progesterone, mice received daily 1 mg/body 
Progeterone
18
 (dissolved in 40 μL sesame oil) 
subcutaneously for 21 days (started on day 8 in 
addition to bleomycin or alone) in (BLM+P) or (P) 
respectively. The injection of bleomycin and 
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progesterone were performed using a 30 and 29 gauge 
needle respectively in separate areas of mice back skin. 
Mice from Control group (PBS) received daily 100 
μL PBS subcutaneously in the same position with 
bleomycin.  
 
Tissue Harvesting and Histological Evaluation 
Under deep anesthesia, the chest was opened and 
lungs were removed. The skin in bleomycin or PBS 
injection site was excised. The left lungs and half of the 
excised injured skins were fixed overnight in 10% 
neutral formalin buffered. Paraffin-embedded lung and 
skin sections of 4μm were stained with hematoxylin 
and eosin for morphological evaluation and with 
Masson‟s trichrome to assess the degree of fibrosis. 
Quantification of pulmonary fibrosis was determined as 
described by Jiang et al.
19
 In brief, trichrome stained 
slides were examined under a light microscope at 200X 
magnification (Olympus BX50, Japan). For each 
specimen, 10 random fields were selected and images 
were taken (Olympus DP12, Japan) then with image j 
software pixels of fibrotic and total area were measured 
and summed. Finally, the percentage of fibrotic area 
per each lung was calculated. The dermis thickness was 
defined as the distance between the epidermal-dermal 
junction and the dermal-subcutaneous fat junction.
20
 
After image acquisition from trichrome sections under 
the light microscope at 100X magnification, the 
thickness was measured by ImageJ software in 5 
different skin field of each specimen. Tissue 




Collagen deposition was estimated by measurement 
of hydroxyproline. After tissue excision, two upper 
lobes from right lungs and the other half of the skins 
immediately were snap frozen and stored at -80˚C until 
used for hydroxyproline assay. Hydroxyproline was 
measured with hydroxyproline assay kit (Sigma 
Aldrich, St. Louis, MO, USA) according to the 
manufacturer protocol.  
 
Terminal Deoxynucleotidyl Transferase (TdT) 
dUTP Nick-End Labeling (TUNEL) Assay  
TUNEL is a method for detecting double-stranded 
low molecular weight DNA fragments in apoptotic 
cells. TdT enzyme catalyzes attachment of 
deoxynucleotides tagged with a marker to 3'-hydroxyl 
termini of DNA double-strand breaks. TUNEL assays 
were performed using In Situ Cell Death Detection Kit 
(Roche Applied Science, 68298 Mannheim, Germany) 
according to the manufacturer‟s instructions. In brief, 
paraffin-embedded lung and skin tissue sections were 
deparaffinized and rehydrated. Permeabilisation of the 
samples was done with protease treatment (Proteinase 
K, 30 min, 370C). Then TUNEL reaction mixture and 
Convertor-POD were added. Finally, sections were 
stained with DAB (3, 3′-Diaminobenzidine 




Experiments were repeated at least twice. Statistical 
analyses were performed by using GraphPad Prism 
software. Groups greater than two were analyzed with 
One-Way ANOVA, tukey multiple comparisons test. 
All data are expressed as Mean±SEM. Differences 




Bleomycin-induced Fibrosis in Skin and Lungs  
Collagen deposition in tissues was used as a 
detection marker for fibrosis. Hydroxyproline and 
trichrome staining were applied for evaluation of 
collagen. In this model, bleomycin injection caused 
fibrosis in skin and lung. The dermal thickness of skin 
from BLM treated mice were approximately three 
times greater than Control group (276.4 µm±35.51 vs. 
94.63 µm±8.348, p<0.001) (Figure 1A, B).  
Hydroxyproline content in the skin of bleomycin-
treated animals increased two-fold compared to the 
control group (2.043 µg±0.2214 vs. 1.014 µg±0.07390, 
p<0.001) (Figure 1C). Dermal thickness and 
hydroxyproline content of skin did not change in 
BLM+P group compared to bleomycin group (p>0.05). 
Progesterone injection alone did not affect the dermal 
thickness and hydroxyproline content compared to the 
PBS group (p>0.05) (Figure 1B, C). 
Trichrome staining showed that subcutaneous 
injection of BLM for four weeks caused pulmonary 
fibrosis. The pulmonary fibrosis was started from 
pleura and subpleural area and extended to the lung 
parenchyma, however in this model central areas of the 
lungs were not affected (Figure 1D) 
Percentage of fibrotic area in the BLM group 
increased significantly in comparison to the control 
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group (p<0.0001). The amount of hydroxyproline in 
lung tissues of mice received bleomycin increased two 
times as compared to the Control group (0.5220 
µg±0.03584 vs. 0.2616 µg±0.004737, p<0.0001) 
(Figure 1E, F). Progesterone injection did not change 
fibrotic areas and hydroxyproline content in the lung of 
bleomycin-treated animals (p>0.05). Progesterone 
injection alone increased fibrotic area (p<0.001) and 
hydroxyproline content (p<0.05) in lung tissue 





Subcutaneous injection of bleomycin caused skin and lung tissues fibrosis in mouse model of systemic sclerosis. Fibrosis 
induced in mice by injection of bleomycin subcutaneously for 28. After 28 days, under lethal anesthesia skin and lung tissues 
were harvested for histological assessment and hydroxyproline measurement. (A) Masson’s trichrome staining of the skin 
tissues. 4 μm of paraffin- embedded skin tissue sections were stained with Masson’s trichrome and examined under a light 
microscope. Original magnification was 100X. (B) Dermis thickness. Dermis thickness was measured from epidermal-dermal 
junction to dermal-subcutaneous fat junction in the skin. (C) Skin hydroxyproline content. (D) Masson’s trichrome staining 
of the lung tissues. 4 μm of paraffin- embedded lung tissue sections were stained with Masson’s trichrome and examined 
under a light microscope. Original magnification was 200X. (E) Percent of fibrotic area in the lung. Lung fibrosis quantitated 
in trichrome staining sections and presented as a percentage. (F) Lung hydroxyproline content. Data were analyzed with One 
–way ANOVA, Tukey multiple comparisons test. Results are presented as Mean ± SEM. N = 9-10 mice in each group. BLM = 
Bleomycin, P = Progesterone, PBS= Control, BLM+P = Bleomycin + Progesterone, , **** = p< 0.0001, *** = p< 0.001, **= p< 
0.01, * = p< 0.05, ns = p> 0.05 
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Apoptotic Cell Count in Skin and Lung  
TUNEL test was used for the detection of apoptotic 
cells (Figure 2A, 3A). Quantification of apoptotic cells 
in stained sections of lungs and layers of skins showed 
that bleomycin caused significant apoptosis in the skin 
(p<0.001) and lungs of mice (p<0.05) (Figure2B, 3B). 
 Progesterone injection in group BLM+P reduced 
apoptotic cells in skin compared to bleomycin group in 
a non-significant manner (37.33%±8.524 vs 
40.93%±3.873, p>0.05). Progesterone injection alone 
did not change the number of apoptotic cells in skin 
compared to PBS group (p>0.05) (Figure 2A, B) 
Progesterone injection reduced the number of 
apoptotic cells in the lung of bleomycin-treated animals 
in a non-significant manner (32.51%±10.84 vs 
44.8%±6.703, p>0.05). Progesterone alone did not alter 
the apoptotic cells in normal lung tissue (p>0.05) 
(Figure 3A, B). 
 
 
Figure 2. Progesterone does not affect apoptosis in skin tissues of bleomycin injured- mouse model. After induction of model 
and intervention of progesterone, under lethal anesthesia injured skin tissues were harvested. Paraffin-embedded skin tissue 
sections were deparaffinized, rehydrated and Permeabilized with Proteinase K. Then TUNEL reaction mixture and 
Convertor-POD were added. Finally, sections were stained with DAB and counterstained with hematoxylin. (A) TUNEL 
staining of skin sections. (B) Percent of apoptotic cells in layers of skin. Apoptotic and normal cells in layers of skin were 
counted then the percent of apoptotic cells were calculated. Data were analyzed with One –way ANOVA, Tukey multiple 
comparisons test. Results are presented as Mean±SEM, N=5 mice in each group. Original magnification was 200X. 
BLM=Bleomycin, P=Progesterone, PBS=Control, BLM+P=Bleomycin+Progesterone, , ns = p>0.05, *** = p<0.001 
 
Figure 3. Progesterone does not affect apoptosis in lung tissues of bleomycin injured - mouse model. After induction of model 
and intervention of progesterone, under lethal anesthesia lung tissues were harvested. Paraffin-embedded lung tissue sections 
were deparaffinized, rehydrated and Permeabilized with Proteinase K. Then TUNEL reaction mixture and Convertor-POD 
were added. Finally, sections were stained with DAB and counterstained with hematoxylin. (A) TUNEL staining of lung 
tissue sections. (B) Percent of apoptotic cells in the lung. Apoptotic and normal cells in lung were counted then the percent of 
apoptotic cells were calculated. Data were analyzed with One –way ANOVA, Tukey multiple comparisons test. Results are 
presented as Mean±SEM, N= 5 mice in each group. Original magnification was 200X. BLM= Bleomycin, P=Progesterone, 
PBS=Control, BLM+P=Bleomycin+Progesterone, ns=p> 0.05, * =p<0.05 
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Our results show that bleomycin causes massive 
cellular apoptosis in skin and lung tissues, however, 
progesterone at supra-physiological (pregnancy 
maintenance) concentrations exerts no effect on skin 
and lung tissue cell apoptosis in bleomycin-induced 
fibrosis. 
Apoptosis is a component of normal cell turnover 
and important for physiological cell loss in most 
tissues. Several regulatory stimuli such as hormones 
influence programmed cell death. Different studies 
proposed that alteration of cell survival and death can 
contribute in pathologies of cancers, viral infections, 
autoimmunity, and neurodegenerative diseases.
21,22
  
Systemic sclerosis is a lethal fibrotic autoimmune 
disease in which tissue homeostasis is disturbed. Cell 
damage with aberrant healing is accepted as important 
pathology in the initiation of disease.
23
 Apoptosis of 
endothelial and epithelial cell is confirmed as a central 
event in the pathogenesis of skin and lung fibrosis.
24-26
 
Anti-endothelial cell antibodies in sera of SSc patients 
caused apoptosis of microvascular endothelial cells and 
leaky vessels which induced the initiation of fibrosis 
cascade.
3,27
 Clinical study revealed that injury of lung 
epithelial cells may occur as an early event in 
asymptomatic patients.
28
 Apoptosis of type 2 
pneumocytes was detected in the pathogenesis of 
idiopathic pulmonary fibrosis.
25
 Some studies used 
bleomycin for induction of fibrosis showed that lung 
epithelial cells are the main targets of induced injuries 
in the lungs. Increased ROS production by bleomycin 
and pursued mitochondrial leakage causes apoptosis in 
epithelial cells
29
 whereas in endothelial cells bleomycin 
activates the extrinsic apoptotic pathway.
30
 Therefore 
one of the actions from bleomycin as a fibrogenic 
factor could be the induction of cell death and fibrosis, 
as is confirmed by our data.  
Our study showed that subcutaneous injection of 
bleomycin for 28 days caused significant apoptosis in 
skin and lungs according to other studies.
31
 In this 
model, significant cell death in lung tissues occurred in 
the periphery while central areas were protected. The 
localization of  dead cells was according to fibrotic 
areas in the lung, thus confirms, the cellular damage as 
a central event in the pathogenesis of fibrosis. Despite 
the constant turnover of cells through apoptosis, 
apoptotic cells are rarely seen under physiological 
conditions, even in tissues with high rates of 
apoptosis.
32
 Therefore presence of great amount of 
apoptotic cells in our study showed disturbance in 
tissue homeostasis and this may contribute in tissue 
fibrosis. 
Since controversial results obtained from different 
studies, the effect of progesterone on cells apoptosis is 
obscure and further investigations are necessary. 
Progesterone acts as an anti-apoptotic agent in ovarian 
and endometrial cells by induction of BCL-xl but, 
prevents the proliferation of ovarian cancer cells.
33-35
 
Whereas progesterone with induction of anti-apoptotic 
agents in injured cardiomyocytes, protects women from 
cardiovascular disease  however, progesterone can 
induce pregnancy-related diabetes through the 
induction of apoptosis in insulin-secreting cells.
 15, 36
 
Anti-apoptotic effect of progesterone causes lung 
cancer cells to become resistant to the action of 
cisplatin. Cisplatin such as bleomycin causes tumor 
cells to be arrested in the G2 phase of the cell cycle and 
mRNA synthesis was inhibited in cancerous cells. 
Inhibition of transcription induces apoptosis in these 
cells.
37
 Despite the fact, that bleomycin and cisplatin 
are both chemotherapeutic agents and act similarly in 
cell apoptosis, our obtained results suggest that 
progesterone cannot alter cell death induced by 
bleomycin. We cannot explain this bias in action of 
progesterone in lung tissue; however, the behavior of 
cancer cells would be different than normal cells of the 
lung. In addition, we can suggest, progesterone could 
not alter the action of bleomycin in chemotherapy but 
this idea needs to be checked in cancerous cells. 
Progesterone, in addition to its reproductive 
functions, has been shown to exhibit the potent 
neuroprotective effect.
38
 After cortical contusion injury, 
the high level of progesterone in female rat reduced 
cerebral edema and these animals had better cognitive 
recovery than males. This event is through an 
increment of anti-apoptotic genes and decrement of 
pro-apoptotic genes expression in neuronal cells.
16
 
Progesterone receptors mediate the effects of 
progesterone by cooperation with a range of 
coregulatory proteins and binding to specific target 
sequences in progesterone-regulated gene promoters. 
Scattering of Progesterone receptors, their coregulatory 
proteins, and targeted gene sequences, differ in various 
cell types and between normal cells with cancer cells. 
Thus this hormone action is specific for each tissue and 
is different in health and disease.
39
 
In this study we did not evaluate the effect of 
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progesterone on apoptosis after the induction of 
scleroderma, also for confirming the results, additional 
methods would be required.
40
 Progesterone affects the 
autoimmune disease by acting on parenchymal cell 
function and by action on immune cells. Therefore for 
complete determining the effect of progesterone on 
systemic sclerosis, other aspects of hormone actions 
such as Th2 induction, M2–type macrophage 




In the present study, we demonstrate that progesterone 
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